A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Painful Lumbar Radiculopathy.
Phase of Trial: Phase II/III
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Lenalidomide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Celgene Corporation
- 01 Sep 2009 Actual patient number (181) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Actual end date changed from Jun 2006 to Nov 2007 as reported by ClinicalTrials.gov.
- 15 Nov 2005 New trial record.